Manjula Mayura Jeyapalan-Noone, MD
General Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 8 carriers
- Offices
- 3
Offices
3 locations
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
28 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jeyapalan-Noone’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A74366 · Current
Licensed to practise in California · since 2001 · expires 2028-10-31 · University of Iowa College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Los Gatos Surgical CenterAmbulatory Surgery Center · Los Gatos, CA0.21% owner since 2006 · accredited by AAAHCAccreditation Renewed6 inspections, 3 with deficiencies · last 2025-04-03
- Los Gatos Surgical CenterSan Jose, CA0.21% owner since 2006 · accredited by AAAHCClosed1 inspection · last 2021-08-10
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$63,724
Medicare paid this office $63,724 for 147 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 35 | $5,533 | $158 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $3,801 | $54 |
| Short return visit (20+ min) | 37 | $3,335 | $86 |
| Return visit (30+ min) | 25 | $3,300 | $122 |
| New patient visit (60+ min) | 13 | $2,671 | $205 |
See all 8 services
| New patient visit (45+ min) | 35 | $5,533 | $158 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $3,801 | $54 |
| Short return visit (20+ min) | 37 | $3,335 | $86 |
| Return visit (30+ min) | 25 | $3,300 | $122 |
| New patient visit (60+ min) | 13 | $2,671 | $205 |
| New patient visit (30+ min) | 23 | $1,606 | $70 |
| Short return visit | 23 | $1,263 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,167 | $106 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Hernia repair (minimally invasive) | 1-10 | None |
| Mastectomy | 21 | More than 80% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 14 | More than 61% of doctors who do this |
| Removal of tissue | 94 | More than 85% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
147 Original Medicare patients in 2024. Average age 76 · Women 72% · Also on Medicaid 11% · Health risk score 1.58. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 44% · Diabetes 33% · Coronary heart disease 33% · Depression 26% · Atrial fibrillation 19% · Heart failure 18% · Chronic kidney disease 18% · COPD 15% · Stroke 14% · Dementia 13%.
The office billed $300,243, Medicare allowed $80,446 and paid $63,724; for 454 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 147 | 454 | 76 | 1.58 | $300,243 | $63,724 |
| 2023 | 116 | 283 | 76 | 1.61 | $145,162 | $35,434 |
| 2022 | 128 | 352 | 77 | 1.77 | $144,590 | $39,035 |
| 2021 | 121 | 410 | 76 | 1.50 | $220,980 | $53,300 |
| 2020 | 127 | 772 | 75 | 1.68 | $348,622 | $71,921 |
| 2019 | 164 | 560 | 76 | 1.78 | $267,632 | $58,370 |
| 2018 | 140 | 503 | 76 | 1.60 | $261,977 | $57,155 |
| 2017 | 129 | 464 | 75 | 1.47 | $222,017 | $48,610 |
| 2016 | 140 | 493 | 77 | 1.72 | $236,379 | $56,506 |
| 2015 | 156 | 623 | 77 | 2.09 | $267,468 | $66,486 |
| 2014 | 155 | 611 | 77 | 1.97 | $240,288 | $63,224 |
| 2013 | 133 | 422 | 76 | 1.88 | $182,751 | $51,282 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| New patient visit (45+ min) | 25 | $3,777 | $151 |
| Short return visit (20+ min) | 24 | $2,261 | $87 |
| New patient visit (30+ min) | 30 | $2,220 | $74 |
| Return visit (30+ min) | 15 | $1,835 | $115 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $1,697 | $55 |
| Short return visit | 14 | $671 | $32 |
2022: 7 services
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $3,987 | $55 |
| New patient visit (45+ min) | 23 | $3,655 | $159 |
| Short return visit (20+ min) | 33 | $2,835 | $81 |
| New patient visit (30+ min) | 29 | $2,115 | $73 |
| Return visit (30+ min) | 11 | $1,481 | $123 |
| Short return visit | 17 | $1,112 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,112 | $93 |
2021: 8 services
| New patient visit (45+ min) | 27 | $4,321 | $160 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $3,578 | $56 |
| Short return visit (20+ min) | 32 | $3,121 | $84 |
| Return visit (30+ min) | 17 | $2,394 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $2,036 | $66 |
| New patient visit (30+ min) | 17 | $1,301 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,134 | $94 |
| Short return visit | 13 | $597 | $33 |
2020: 10 services
| Management of oxygen chamber therapy | 15 | $15,542 | $100 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $7,165 | $55 |
| New patient visit (45+ min) | 23 | $3,606 | $157 |
| Return visit (30+ min) | 24 | $2,527 | $101 |
| Short return visit (20+ min) | 29 | $2,480 | $67 |
| New patient visit (60+ min) | 12 | $2,357 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,659 | $66 |
| New patient visit (30+ min) | 17 | $1,099 | $65 |
| Application of chemical to stop tissue regrowth in wound | 12 | $976 | $30 |
| Short return visit | 16 | $515 | $23 |
2019: 8 services
| Removal of skin and tissue, 20.0 sq cm or less | 41 | $6,353 | $53 |
| Management of oxygen chamber therapy | 12 | $6,107 | $93 |
| New patient visit (45+ min) | 35 | $5,109 | $146 |
| New patient visit (30+ min) | 39 | $2,428 | $62 |
| Short return visit (20+ min) | 30 | $2,124 | $62 |
| Return visit (30+ min) | 11 | $1,086 | $99 |
| Short return visit | 24 | $844 | $21 |
| Short return visit (20+ min) | 12 | $703 | $44 |
2018: 9 services
| Removal of gallbladder using an endoscope | 15 | $7,223 | $482 |
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $5,435 | $55 |
| Short return visit (20+ min) | 41 | $3,284 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,537 | $63 |
| New patient visit (45+ min) | 18 | $2,532 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,471 | $177 |
| New patient visit (30+ min) | 27 | $1,781 | $66 |
| New patient visit (30+ min) | 13 | $1,282 | $99 |
| Short return visit | 22 | $824 | $22 |
2017: 9 services
| Removal of gallbladder using an endoscope | 14 | $7,326 | $523 |
| Management of oxygen chamber therapy | 12 | $5,866 | $93 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $5,051 | $54 |
| New patient visit (45+ min) | 22 | $3,152 | $143 |
| Short return visit (20+ min) | 32 | $2,391 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,264 | $174 |
| Short return visit | 25 | $1,287 | $22 |
| New patient visit (30+ min) | 12 | $1,168 | $97 |
| New patient visit (30+ min) | 17 | $1,109 | $65 |
2016: 12 services
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $4,743 | $54 |
| Removal of gallbladder using an endoscope | 11 | $4,722 | $429 |
| Management of oxygen chamber therapy | 11 | $4,077 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,424 | $173 |
| Short return visit (20+ min) | 30 | $2,373 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,038 | $62 |
| New patient visit (45+ min) | 13 | $1,898 | $146 |
| New patient visit (30+ min) | 28 | $1,823 | $65 |
| New patient visit (30+ min) | 13 | $1,257 | $97 |
| Return visit (30+ min) | 11 | $1,257 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,184 | $85 |
| Short return visit | 16 | $643 | $21 |
2015: 11 services
| Management of oxygen chamber therapy | 18 | $6,817 | $95 |
| Removal of skin and tissue, 20.0 sq cm or less | 30 | $3,801 | $54 |
| New patient visit (45+ min) | 25 | $3,667 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,540 | $63 |
| Short return visit (20+ min) | 32 | $2,794 | $63 |
| Short return visit (20+ min) | 22 | $2,442 | $44 |
| New patient visit (30+ min) | 25 | $1,656 | $66 |
| Return visit (30+ min) | 14 | $1,480 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,272 | $91 |
| Application of chemical to stop tissue regrowth in wound | 13 | $958 | $32 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 11 | $491 | $22 |
2014: 13 services
| Removal of gallbladder using an endoscope | 16 | $7,285 | $455 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,497 | $180 |
| New patient visit (45+ min) | 28 | $4,250 | $152 |
| Short return visit (20+ min) | 30 | $2,909 | $66 |
| Removal of skin and tissue, 20.0 sq cm or less | 23 | $2,494 | $55 |
| Return visit (30+ min) | 14 | $1,822 | $96 |
| Removal of tissue from wound, 20.0 sq cm or less | 32 | $1,622 | $21 |
| Short return visit (20+ min) | 23 | $1,456 | $45 |
| New patient visit (45+ min) | 12 | $1,387 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,217 | $64 |
| Short return visit | 21 | $1,137 | $22 |
| Application of chemical to stop tissue regrowth in wound | 11 | $917 | $34 |
| New patient visit (30+ min) | 11 | $743 | $68 |
2013: 10 services
| Management of oxygen chamber therapy | 17 | $5,105 | $104 |
| New patient visit (45+ min) | 30 | $4,442 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,275 | $175 |
| New patient visit (45+ min) | 17 | $1,916 | $113 |
| Short return visit (20+ min) | 21 | $1,518 | $63 |
| Return visit (30+ min) | 12 | $1,300 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,222 | $87 |
| Short return visit | 23 | $992 | $21 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $919 | $19 |
| Application of chemical to stop tissue regrowth in wound | 11 | $652 | $34 |
Drugs they prescribed that Part D paid
$3,051
Pharmacies billed $3,051 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 64% of their Part D prescriptions (29 of 45) in 2024. Too few prescriptions to compare fairly with other clinicians.
37 generic and fewer than 11 brand-name prescriptions · $3,051 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 23 | $138 | $6 |
Year by year
| 2024 | 45 | 36 | 64% (29) | None | $3,051 |
| 2023 | 48 | 32 | 44% (21) | None | $3,424 |
| 2022 | 35 | 25 | 51% (18) | None | $3,121 |
| 2021 | 38 | 25 | 61% (23) | None | $1,138 |
| 2020 | 45 | 30 | 51% (23) | None | $1,768 |
| 2019 | 60 | 41 | 55% (33) | None | $2,330 |
| 2018 | 67 | 39 | 45% (30) | 19% | $3,283 |
| 2017 | 49 | 30 | 41% (20) | 22% | $2,468 |
| 2016 | 79 | 35 | 33% (26) | 14% | $2,987 |
| 2015 | 90 | 48 | 48% (43) | 13% | $2,456 |
| 2014 | 84 | 41 | 38% (32) | 18% | $3,215 |
| 2013 | 64 | 35 | 34% (22) | None | $3,697 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydrocodone-Acetaminophen | 21 | $102 | $5 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 17 | $100 | $6 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 18 | $103 | $6 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 23 | $119 | $5 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 32 | $165 | $5 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 26 | $174 | $7 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 19 | $142 | $7 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 24 | $280 | $12 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 38 | $342 | $9 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 30 | $369 | $12 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 22 | $307 | $14 |
Money from drug and device companies
$303 in 2025
| 2025 | 2 | 3 | None | $303 |
| 2024 | 2 | 6 | None | $519 |
| 2023 | 3 | 3 | None | $188 |
| 2022 | 1 | 1 | None | $117 |
| 2021 | 1 | 1 | None | $15 |
| 2020 | 3 | 3 | None | $200 |
| 2019 | 3 | 3 | None | $290 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $182 | 2 payments
|
| Organogenesis | Puraply Wound Matrix | $121 | 1 payment
|
See all 3 published payments
| Organogenesis | Meals · 2025-12-03 | Puraply Wound Matrix | $121 |
| TELA Bio | Meals · 2025-10-15 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $57 |
| TELA Bio | Meals · 2025-06-25 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $519
| Intuitive Surgical | Da Vinci Surgical System | $432 | 5 payments
|
| TELA Bio | Ovitex 2s | $88 | 1 payment
|
2023: $188
| Musculoskeletal Transplant Foundation | None | $131 | 1 payment
|
| Smith+Nephew | Grafix | $34 | 1 payment
|
| Ethicon US | Harmonic | $23 | 1 payment
|
2022: $117
| Horizon Therapeutics plc | Tepezza | $117 | 1 payment
|
2021: $15
| Braintree Laboratories | Sutab | $15 | 1 payment
|
2020: $200
| Kci USA | Prevena | $122 | 1 payment
|
| Acell | None | $59 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $18 | 1 payment
|
2019: $290
| Davol | Phasix | $140 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $134 | 1 payment
|
| Smith+Nephew | Grafix Pl Prime | $17 | 1 payment
|
Professional record
- NPI
- 1598785198
- Licence
- CA A74366California A74366: Current · expires 2028-10-31
- Trained
- University of Iowa, Rj & L Carver College of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 15195 National Ave, Ste 206, Los Gatos, CA, 95032
- NPI first listed
- 2006-07-20
- NPI last updated
- 2024-05-17
- NPI record certified
- 2024-05-17
This is when the NPI record was last certified, not a medical board exam.